IPEX as a result of mutations in FOXP3

Clinical and Developmental Immunology

Volumn 2007, Issue , 2007, Pages

  Van Der Vliet, Hans J J ^a   Nieuwenhuis, Edward E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 2; METHOTREXATE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

APOPTOSIS; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DERMATITIS; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENTEROPATHY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENERAL ASPECTS OF DISEASE; HOMEOSTASIS; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; LABORATORY TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SYMPTOM; T CELL DEPLETION; THYROIDITIS; TREATMENT INDICATION; TREATMENT OUTCOME; X CHROMOSOME; AUTOIMMUNE POLYENDOCRINOPATHY; GENETICS; IMMUNOLOGY; MUTATION; PATHOLOGY; X CHROMOSOME LINKED DISORDER;

FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES, REGULATORY;

EID: 36248970573     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2007/89017     Document Type: Review

References (28)

1. B. R. Powell N. R. M. Buist P. Stenzel An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. The Journal of Pediatrics 100 5 1982 731 737
2. T. R. Torgerson troy.torgerson@seattlechildrens.org Regulatory T cells in human autoimmune diseases. Springer Seminars in Immunopathology 28 1 2006 63 76
3. R. S. Wildin S. Smyk-Pearson A. H. Filipovich Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. Journal of Medical Genetics 39 8 2002 537 545
4. R. S. Wildin F. Ramsdell J. Peake X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 27 1 2001 18 20
5. C. L. Bennett J. Christie F. Ramsdell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 27 1 2001 20 21
6. M. E. Brunkow E. W. Jeffery K. A. Hjerrild Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 27 2001 1 68 73
7. C. J. Owen c.j.owen@ncl.ac.uk C. E. Jennings H. Imrie Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. The Journal of Clinical Endocrinology & Metabolism 88 12 2003 6034 6039
8. C. L. Bennett M. E. Brunkow F. Ramsdell A rare polyadenylation signal mutation of the FOXP3 gene ( AAUAAA → AAUGAA) leads to the IPEX syndrome. Immunogenetics 53 6 2001 435 439
9. A. K. Myers L. Perroni C. Costigan W. Reardon willie.reardon@olhsc.ie Clinical and molecular findings in IPEX syndrome. Archives of Disease in Childhood 91 1 2006 63 64
10. S. Le Bras R. S. Geha raif.geha@childrens.harvard.edu IPEX and the role of FOXP3 in the development and function of human Tregs. Journal of Clinical Investigation 116 6 2006 1473 1475
11. S. F. Ziegler sziegler@vmresearch.org FOXP3: of mice and men. Annual Review of Immunology 24 2006 209 226
12. J. E. Lopes T. R. Torgerson L. A. Schubert Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. The Journal of Immunology 177 5 2006 3133 3142
13. D. J. Campbell S. F. Ziegler sziegler@benaroyaresearch.org FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nature Reviews Immunology 7 4 2007 305 310
14. M. Kronenberg mitch@liai.org A. Rudensky aruden@u.washington.edu Regulation of immunity by self-reactive T cells. Nature 435 7042 2005 598 604
15. L. A. Schubert E. Jeffery Y. Zhang F. Ramsdell S. F. Ziegler sziegler@vmresearch.org Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. Journal of Biological Chemistry 276 40 2001 37672 37679
16. Y. Wu M. Borde V. Heissmeyer FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 2 2006 375 387
17. S. Sakaguchi shimon@frontier.kyoto-u.ac.jp Naturally arising FOXP3-expressing CD 25+ CD 4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 6 4 2005 345 352
18. O. Baud O. Goulet D. Canioni Treatment of the immune dysregulation, polyendoccrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. The New England Journal of Medicine 344 23 2001 1758 1762
19. M. L. Heltzer heltzer@email.chop.edu J. K. Choi H. D. Ochs K. E. Sullivan T. R. Torgerson L. M. Ernst A potential screening tool for IPEX syndrome. Pediatric and Developmental Pathology 10 2 2007 98 105
20. L. Bindl T. Torgerson L. Perroni Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). The Journal of Pediatrics 147 2 2005 256 259
21. P. J. Ferguson pjf2d@virginia.edu S. H. Blanton F. T. Saulsbury Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. American Journal of Medical Genetics 90 5 2000 390 397
22. N. Satake M. Nakanishi M. Okano A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy. European Journal of Pediatrics 152 4 1993 313 315
23. I. Kobayashi M. Nakanishi M. Okano Y. Sakiyama S. Matsumoto Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. European Journal of Pediatrics 154 7 1995 594 595
24. I. Kobayashi N. Kawamura M. Okano A long-term survivor with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. The New England Journal of Medicine 345 13 2001 999 1000
25. R. Bacchetta L. Passerini E. Gambineri Defective regulatory and effector T cell functions in patients with FOXP3 mutations. Journal of Clinical Investigation 116 6 2006 1713 1722
26. A. Rao N. Kamani A. Filipovich Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 109 1 2007 383 385
27. T. J. Curiel G. Coukos L. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine 10 9 2004 942 949
28. J. Dannull Z. Su D. Rizzieri Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. Journal of Clinical Investigation 115 12 2005 3623 3633